Nanomedicine News

RSS

University of Kentucky Researcher Recognized for RNA Nanoparticles Study

University of Kentucky researcher Yi Shu was awarded the Best Poster Presentation at the National Cancer Institute Alliance for Nanotechnology in Cancer's Annual Principal Investigators' Meeting last month.

7 Dec 2012

Femtosecond Crystallography Reveals 3D Structure of Enzyme Linked to Sleeping Sickness

An international team of scientists, using the world's most powerful X-ray laser, has revealed the three dimensional structure of a key enzyme that enables the single-celled parasite that causes African trypanosomiasis (or sleeping sickness) in humans.

From Arizona State University 6 Dec 2012

Fungal Nanoparticles Activate Secretion of Immune-System Stimulant

Arthrobotrys oligospora doesn’t live a charmed life; it survives on a diet of roundworm.

6 Dec 2012

Novel Nanotechnology Holds Hope for Treatment of Pediatric Leukemia

Nanotechnology developed by Delaware scientists could potentially deliver chemotherapy to children in a way that attacks cancer cells without harming healthy cells, greatly reducing side effects.

5 Dec 2012

AOAC Certifies FoodChek’s MICT Nanotechnology Based Listeria spp. Testing

FoodChek Systems Inc. ("FoodChek" or the "Corporation") is very proud to announce that the AOAC Research Institute, the approval body for all U.S. food safety tests, has validated and certified as a Performance Tested Method ("PTM"), FoodChek's patent pending Actero™ Listeria Enrichment Media (License #111201) and the FoodChek™ Listeria spp. Assay Cassette (License #111202).

3 Dec 2012

Genisphere, LIMR Partner to Develop Cancer Nanotherapies

Genisphere and the nonprofit Lankenau Institute for Medical Research (LIMR), which are already making progress together on identifying Inflammatory Bowel Disease biomarkers, have partnered to develop nanotherapeutics targeting cancers and eye diseases.

3 Dec 2012

Nanofiber Synthetic Scaffolds Used in Successful Laryngotracheal Implants

With headlines filled with global turmoil, it is always refreshing to see that, within the realm of biomedical research, national boundaries are being successfully transcended, paving the way for a truly worldwide effort to improve lives.

3 Dec 2012

Selecta Biosciences, Sanofi Collaborate on Development of Antigen-Specific Immunotherapies

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has entered into a strategic global collaboration with Sanofi to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies.

29 Nov 2012

New-Generation Age Control Body Cream from Nanotechnology Company BIONOVA

Many people are concerned with changes in their body shape as they age. Changes related to the aging process cause structural transformation of proteins in deep layers of the skin, promoting skin dryness, reduction of skin thickness, papery look, sagginess and other typical for aging processes symptoms. The best solution is to prevent and slow down the skin structural changes.

28 Nov 2012

Mentor Capital, Nanovega Ink LOI to Scale Up Nano-Scale Synthetic Antibodies Production

Mentor Capital, Inc. announced it has executed a Letter of Intent with Nanovega, Inc. for $6 million to fund the production scale up of its ultra-small synthetic antibodies. These nano-scale molecules are approximately one-tenth the size of most alternative cancer delivery bio-markers. The small size allows the nano-bodies to slip throughout solid tumors instead of piling up at the surface as is often currently encountered in cancer treatment.

21 Nov 2012